Table 4.
Anthropometric data (Mean± SD) in 2 groups of children with Down Syndrome (DS) ( >1 yr) with high TSH before and after treatment with L-thyroxine compared to DS subjects with normal thyroid function
| Groups | Age-1 (yr) | Ht-SDS (1) | BMI-SDS (1) | Age-2 (yr) | Ht-SDS (2) | BMI-SDS (2) | Δ Ht-SDS | Δ BMI-SDS | |
| TSH >12 mIU/L or FT4 <9 pmol/L | Mean | 3.86 | -2.15 | -0.77 | 7.73 | -2.39 | 0.66* | -0.24 | 1.43 |
| Treated | SD | 5.63 | 1.46 | 2.63 | 5.52 | 1.01 | 1.69 | 1.32 | 2.49 |
| TSH >5 and <12 mIU/L | Mean | 2.88 | -1.57 | 0.38 | 8.88 | -2.18 | 1.37* | -0.62 | 1.23 |
| Treated | SD | 2.70 | 1.04 | 1.82 | 5.04 | 1.27 | 1.98 | 1.09 | 3.25 |
| Normal thyroid function | Mean | 1.64 | -1.90 | -0.13 | 4.65 | -2.08 | 0.59* | -0.17 | 0.69 |
| SD | 2.03 | 1.36 | 1.68 | 2.81 | 0.93 | 1.48 | 0.97 | 1.41 | |
| P value | 0.08 | 0.1182 | 0.089 | <0.00 | 0.47 | 0.29 | 0.21 | 0.28 |
Abbreviations: 1 = before treatment, 2 = after treatment with L-thyroxine